COGNITION THERAPEUTICS INC — Director's Dealing 2021

Oct 13, 2021

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: COGNITION THERAPEUTICS INC (CGTX)
CIK: 0001455365
Period of Report: 2021-10-07

Reporting Person: Ricciardi Lisa (Director, CEO & President)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2021-10-07	Stock Option (right to buy)	$12.00	A	547965	Acquired	2030-06-01	Common Stock (547965)	Direct
2021-10-07	Stock Option (right to buy)	$12.00	A	290509	Acquired	2031-10-12	Common Stock (290509)	Direct
2021-10-07	Stock Option (right to buy)	$12.00	A	290509	Acquired	2031-10-12	Common Stock (290509)	Direct

Footnotes

F1: - 25% of the shares of common stock underlying the option vested on June 1, 2021. The remaining shares underlying the option vest in equal monthly installments thereafter for thirty-six (36) months, on the last day of each
such month.

F2: - 25% of the shares of common stock underlying the option vest on the closing of the issuer's initial public offering. The remaining shares underlying the option vest in equal monthly installments thereafter for thirty-six (36)
months, on the last day of each such month.